Jon Stanley Morrow PhD, MD

Raymond Yesner Professor of Pathology; Chair, Department of Pathology; Chief of Pathology at YNHH

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Office of Student ResearchCancer Center, Yale: Signal TransductionPathology: Surgical Pathology; Morrow Lab; ExPathPediatric PathologySignal Transduction

Research Interests

Hemolytic Disease; Degenerative Brain Disease; spectrin; Autopsy Pathology; Renal Pathology; Medical Informatics; Computer Aided Instruction (CAI); Telepathology

Clinical Interests

Hematologic and renal disorders; kidney cancer; colon cancer; breast cancer


  • Ph.D., Indiana University School of Medicine , 1974
  • M.D., Yale University , 1976

Selected Publication

  • Glantz, S.B., Cianci, C.D., Iyer, R., Pradhan, D., Wang, K.K., and Morrow, J.S. (2007). Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochem. 46(2):502-13.
Download on the Apple App Store